检索结果 - Hartmut Goldschmidt
- Showing 1 - 20 results of 177
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Polymorphisms of the tumor necrosis factor-α gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma 由 Kai Neben, Joannis Mytilineos, Thomas Moehler, Astrid Preiss, Alwin Kraemer, Anthony D. Ho, Gerhard Opelz, Hartmut Goldschmidt
出版 2002Artigo -
13
-
14
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and live... 由 Falk‐Udo Sack, Arnt V. Kristen, Hartmut Goldschmidt, Philipp A. Schnabel, Thomas J. Dengler, Achim Koch, Matthias Karck
出版 2007Artigo -
15
-
16
Analysis of long‐term survival in multiple myeloma after first‐line autologous stem cell transplantation: impact of clinical risk factors and sustained response 由 Nicola Lehners, Natália Becker, Axel Benner, Maria Pritsch, Martin Löpprich, Elias Karl, Jens Hillengaß, Hartmut Goldschmidt, Marc S. Raab
出版 2017Artigo -
17
-
18
-
19
Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone 由 Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengaß, Marc S. Raab, Anja Seckinger, Dirk Hose, Anthony D. Ho, Hartmut Goldschmidt, Kai Neben
出版 2010Artigo -
20
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays 由 Karène Mahtouk, Jérôme Moreaux, Dirk Hose, Thierry Rème, Tobias Meißner, Michel Jourdan, Jean François Rossi, Steven T. Pals, Hartmut Goldschmidt, Bernard Klein
出版 2010Artigo
相关主题
Medicine
Multiple myeloma
Internal medicine
Oncology
Biology
Immunology
Genetics
Gene
Surgery
Cancer research
Lenalidomide
Gastroenterology
Dexamethasone
Bortezomib
Bone marrow
Transplantation
Chemotherapy
Physics
Pathology
Antibody
Clinical trial
Biochemistry
Confidence interval
Adverse effect
Autologous stem-cell transplantation
Thalidomide
Melphalan
Refractory (planetary science)
Astrobiology
Carfilzomib